Ignite Creation Date:
2024-05-06 @ 2:11 PM
Last Modification Date:
2024-10-26 @ 1:26 PM
Study NCT ID:
NCT04241393
Status:
COMPLETED
Last Update Posted:
2020-11-17
First Post:
2020-01-22
Brief Title:
An Open-label Trial to Evaluate Mass Balance of Tavapadon at Steady State in Healthy Subjects
Sponsor:
Cerevel Therapeutics LLC
Organization:
Cerevel Therapeutics LLC
Study Overview
Official Title:
An Open-label Trial to Evaluate the Absorption Metabolism and Excretion of a Single Dose of 14C-Tavapadon in Healthy Adult Male Subjects at Steady State
Status:
COMPLETED
Status Verified Date:
2020-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this trial is to determine the absorption metabolism and excretion AME of 14C tavapadon
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None